UDP-galactopyranose mutase

interconverts UDP-galactopyranose to UDP-galactofuranose; contains a flavin cofactor identified as flavin adenine dinucleotide

Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

1.	Sobrado, Pablo: 2 articles (01/2019 - 01/2012)
2.	Sanders, David A R: 2 articles (12/2016 - 05/2005)
3.	Cossio-Pérez, Rodrigo: 1 article (01/2019)
4.	Palma, Juliana: 1 article (01/2019)
5.	Pierdominici-Sottile, Gustavo: 1 article (01/2019)
6.	Akhter, Yusuf: 1 article (01/2018)
7.	Arish, Mohd: 1 article (01/2018)
8.	Husein, Atahar: 1 article (01/2018)
9.	Kalaiarasan, Ponnusamy: 1 article (01/2018)
10.	Kashif, Mohammad: 1 article (01/2018)

1.	Tuberculosis (Tuberculoses) 05/13/2005 - "Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae UDP-galactopyranose mutase in the oxidised state and Klebsiella pneumoniae UDP-galactopyranose mutase in the (active) reduced state." 12/02/2016 - "UDP-galactopyranose mutase (UGM), a key enzyme in the biosynthesis of mycobacterial cell walls, is a potential target for the treatment of tuberculosis. " 10/01/2008 - "For example, advances in structure-based inhibitor design against the mycobacterial enzyme UDP-galactopyranose mutase offer new hope in next generation anti-tuberculosis chemotherapeutics. " 01/01/2017 - "tuberculosis In each species, the galactan is constructed from uridine 5'-diphosphate-α-d-galactofuranose (UDP-Galf), which is generated by the enzyme UDP-galactopyranose mutase (UGM or Glf). "
2.	Chagas Disease (American Trypanosomiasis) 01/01/2012 - "Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease."
3.	Leishmaniasis 01/01/2018 - "Identification of novel inhibitors against UDP-galactopyranose mutase to combat leishmaniasis."
4.	Infections 01/01/2019 - "The enzyme UDP-galactopyranose mutase (UGM) represents a promising drug target for the treatment of infections with Trypanosoma cruzi. "